2013 - ISODP 2013 Congress


Oral Presentation 6 on Deceased Donor Management

13.1 - SEUSA Program, an international collaborative strategy to increase deceased organ donor activity

Presenter: Maria Paula, Gomez Gomez, Barcelona, Spain
Authors: Maria Paula Gómez Gómez, Martí Manyalich, Xavier Guasch, José Manuel García Buitron, Antonio Fernández, Lesley Roberts, José Ignacio Sánchez, Antoine Stephan, Farida Younan, Francesco Paolo Schena


SEUSA Program, an international collaborative strategy to increase deceased organ donor activity

Maria Paula Gómez Gómez1, Martí Manyalich1, Xavier Guasch1, José Manuel García Buitron2, Antonio Fernández2, Lesley Roberts3, José Ignacio Sánchez4, Antoine Stephan5, Farida Younan5, Francesco Paolo Schena6

1DTI Foundation, Barcelona, Spain, 2Juan Canalejo Hospital, A Coruña, Spain, 3National Organ Transplant Unit (NOTU), Port of Spain, Trinidad and Tobago, 4Regional coordination of transplantations of Aragon, Zaragoza, Spain, 5National Organization for Organ and Tissue Donation and Transplantation (NOOTDT), Beirut, Lebanon, 6Apulia Transplant Regional Center, Azienda Ospedaliero-Universitaria Policlinico di Bari, Bari, Italy

Objective: The SEUSA is a program to improve the organ donation and transplant system based on the best practices of the Spanish, European and USA models. The objective of the present study is to collect evidence of the effectiveness of the SEUSA increasing the deceased organ donation from the experience of implementation in three regions, the South of Italy (La Puglia), Lebanon and Trinidad and Tobago.

Method: The SEUSA includes: 1) Diagnose of the organ donation and transplantation activity through the “Organ Donation Diagnosis Survey” (ODDS); 2) Establishment of the Transplant Procurement Management Team; 3) Implementation of the “Deceased Alert System” (DAS); 4) Application of the “Essential in Organ Donation” (EOD) and 5) Hospital Audit. Monthly monitoring meetings to make needed adjustments based on the specific characteristics of the country are done. The program also contributes with the definition of specific economic funds direct to the procurement system.

Results: SEUSA-Apulia started in 2007 and after three years of implementation, comparing to the data from the three previous years of the project  (2005-2006-2007) we found an increase of 36.5% of brain death diagnose (83 vs. 113.3) and the total number of donors increased to 47% (89 vs. 131). SEUSA-Lebanon started in 2009. So far, SEUSA has increased Lebanon’s donation rate from 0 to 2.5 PMP and it has been possible to implement the cornea donation program, obtaining 90 cornea donors. SEUSA-Trinidad and Tobago is currently being implemented and started on July 2010. During the first year of DAS 161 alerts of possible DBD and DCD happened, from them 17 Brain death were diagnosed.

Conclusion: The SEUSA has contributed to the improvement of the organ donation/transplant system in the three regions. In addition, it may represent an example of valuable and replicable strategy to ameliorate organ and tissue activity in other countries.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi